nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—EGFR—sarcoma	0.16	1	CbGaD
Docetaxel—head and neck cancer—sarcoma	0.115	0.302	CtDrD
Docetaxel—melanoma—sarcoma	0.101	0.265	CtDrD
Docetaxel—skin cancer—sarcoma	0.094	0.247	CtDrD
Docetaxel—lung cancer—sarcoma	0.0708	0.186	CtDrD
Docetaxel—TUBB6—Vincristine—sarcoma	0.0213	0.0669	CbGbCtD
Docetaxel—TUBB8—Vincristine—sarcoma	0.0213	0.0669	CbGbCtD
Docetaxel—TUBB2A—Vincristine—sarcoma	0.0213	0.0669	CbGbCtD
Docetaxel—TUBB2B—Vincristine—sarcoma	0.0213	0.0669	CbGbCtD
Docetaxel—TUBB4A—Vincristine—sarcoma	0.0213	0.0669	CbGbCtD
Docetaxel—TUBB3—Vincristine—sarcoma	0.0213	0.0669	CbGbCtD
Docetaxel—TUBB1—Vincristine—sarcoma	0.0178	0.056	CbGbCtD
Docetaxel—TUBB4B—Vincristine—sarcoma	0.0178	0.056	CbGbCtD
Docetaxel—TUBB—Vincristine—sarcoma	0.0178	0.056	CbGbCtD
Docetaxel—ABCC10—Vincristine—sarcoma	0.0136	0.0428	CbGbCtD
Docetaxel—ABCC10—Etoposide—sarcoma	0.0125	0.0392	CbGbCtD
Docetaxel—CYP1B1—Mitoxantrone—sarcoma	0.0108	0.0338	CbGbCtD
Docetaxel—ABCC1—Dactinomycin—sarcoma	0.00854	0.0268	CbGbCtD
Docetaxel—ABCC10—Doxorubicin—sarcoma	0.00851	0.0267	CbGbCtD
Docetaxel—ABCC1—Mitoxantrone—sarcoma	0.00764	0.024	CbGbCtD
Docetaxel—ABCC1—Epirubicin—sarcoma	0.00618	0.0194	CbGbCtD
Docetaxel—ABCG2—Dactinomycin—sarcoma	0.00571	0.0179	CbGbCtD
Docetaxel—ABCC1—Vincristine—sarcoma	0.00526	0.0165	CbGbCtD
Docetaxel—ABCG2—Mitoxantrone—sarcoma	0.00511	0.0161	CbGbCtD
Docetaxel—ABCC1—Etoposide—sarcoma	0.00482	0.0151	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—sarcoma	0.00463	0.0145	CbGbCtD
Docetaxel—ABCC2—Vincristine—sarcoma	0.00389	0.0122	CbGbCtD
Docetaxel—ABCC2—Etoposide—sarcoma	0.00357	0.0112	CbGbCtD
Docetaxel—ABCG2—Vincristine—sarcoma	0.00352	0.0111	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—sarcoma	0.00329	0.0103	CbGbCtD
Docetaxel—ABCG2—Etoposide—sarcoma	0.00322	0.0101	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0026	0.00816	CbGbCtD
Docetaxel—CYP3A7—Vincristine—sarcoma	0.0026	0.00816	CbGbCtD
Docetaxel—CYP3A4—Thiotepa—sarcoma	0.00257	0.00807	CbGbCtD
Docetaxel—ABCC2—Doxorubicin—sarcoma	0.00243	0.00764	CbGbCtD
Docetaxel—ABCG2—Doxorubicin—sarcoma	0.0022	0.00691	CbGbCtD
Docetaxel—ABCB1—Dactinomycin—sarcoma	0.00206	0.00647	CbGbCtD
Docetaxel—CYP3A5—Vincristine—sarcoma	0.00195	0.00612	CbGbCtD
Docetaxel—ABCB1—Mitoxantrone—sarcoma	0.00184	0.00579	CbGbCtD
Docetaxel—CYP3A5—Etoposide—sarcoma	0.00179	0.00561	CbGbCtD
Docetaxel—ABCB1—Vincristine—sarcoma	0.00127	0.00398	CbGbCtD
Docetaxel—ABCB1—Etoposide—sarcoma	0.00116	0.00365	CbGbCtD
Docetaxel—CYP3A4—Mitoxantrone—sarcoma	0.0011	0.00347	CbGbCtD
Docetaxel—KIF11—embryo—sarcoma	0.000846	0.0281	CbGeAlD
Docetaxel—ABCB1—Doxorubicin—sarcoma	0.000793	0.00249	CbGbCtD
Docetaxel—CYP3A4—Vincristine—sarcoma	0.00076	0.00239	CbGbCtD
Docetaxel—KIF11—Teniposide—Etoposide—sarcoma	0.000707	0.592	CbGdCrCtD
Docetaxel—CYP3A4—Etoposide—sarcoma	0.000697	0.00219	CbGbCtD
Docetaxel—MAP4—mammary gland—sarcoma	0.000572	0.019	CbGeAlD
Docetaxel—EGFR—mammary gland—sarcoma	0.000513	0.0171	CbGeAlD
Docetaxel—KIF11—tendon—sarcoma	0.0005	0.0166	CbGeAlD
Docetaxel—KIF11—Vinblastine—Vincristine—sarcoma	0.000486	0.408	CbGdCrCtD
Docetaxel—KIF11—bone marrow—sarcoma	0.000484	0.0161	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—sarcoma	0.000475	0.00149	CbGbCtD
Docetaxel—KIF11—testis—sarcoma	0.000414	0.0138	CbGeAlD
Docetaxel—MAP4—embryo—sarcoma	0.00039	0.013	CbGeAlD
Docetaxel—TUBB3—hematopoietic system—sarcoma	0.000348	0.0116	CbGeAlD
Docetaxel—MAP4—hematopoietic system—sarcoma	0.000348	0.0116	CbGeAlD
Docetaxel—TUBB1—hematopoietic system—sarcoma	0.00034	0.0113	CbGeAlD
Docetaxel—TUBB3—connective tissue—sarcoma	0.000335	0.0111	CbGeAlD
Docetaxel—MAP4—connective tissue—sarcoma	0.000335	0.0111	CbGeAlD
Docetaxel—MAP2—myometrium—sarcoma	0.000319	0.0106	CbGeAlD
Docetaxel—BCL2—hematopoietic system—sarcoma	0.000317	0.0105	CbGeAlD
Docetaxel—TUBB6—mammary gland—sarcoma	0.000312	0.0104	CbGeAlD
Docetaxel—MAP2—embryo—sarcoma	0.000307	0.0102	CbGeAlD
Docetaxel—BCL2—connective tissue—sarcoma	0.000305	0.0101	CbGeAlD
Docetaxel—MAP4—skin of body—sarcoma	0.000303	0.0101	CbGeAlD
Docetaxel—KIF11—lymph node—sarcoma	0.0003	0.00998	CbGeAlD
Docetaxel—MAPT—tendon—sarcoma	0.000293	0.00975	CbGeAlD
Docetaxel—MAP2—seminal vesicle—sarcoma	0.000288	0.00959	CbGeAlD
Docetaxel—TUBB8—testis—sarcoma	0.00028	0.0093	CbGeAlD
Docetaxel—BCL2—smooth muscle tissue—sarcoma	0.000279	0.00927	CbGeAlD
Docetaxel—NR1I2—liver—sarcoma	0.000276	0.00917	CbGeAlD
Docetaxel—BCL2—skin of body—sarcoma	0.000275	0.00915	CbGeAlD
Docetaxel—MAP2—hematopoietic system—sarcoma	0.000274	0.00912	CbGeAlD
Docetaxel—TUBB4B—mammary gland—sarcoma	0.000271	0.00902	CbGeAlD
Docetaxel—MAP4—uterus—sarcoma	0.000263	0.00874	CbGeAlD
Docetaxel—TUBB3—lymphoid tissue—sarcoma	0.000245	0.00815	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—sarcoma	0.000245	0.00815	CbGeAlD
Docetaxel—MAPT—testis—sarcoma	0.000243	0.00807	CbGeAlD
Docetaxel—BCL2—uterus—sarcoma	0.000239	0.00795	CbGeAlD
Docetaxel—TUBB2B—myometrium—sarcoma	0.000239	0.00793	CbGeAlD
Docetaxel—TUBB4A—embryo—sarcoma	0.000237	0.00789	CbGeAlD
Docetaxel—EGFR—uterus—sarcoma	0.000236	0.00785	CbGeAlD
Docetaxel—MAP4—tendon—sarcoma	0.00023	0.00766	CbGeAlD
Docetaxel—TUBB—myometrium—sarcoma	0.000226	0.0075	CbGeAlD
Docetaxel—TUBB2A—myometrium—sarcoma	0.000225	0.00746	CbGeAlD
Docetaxel—BCL2—lymphoid tissue—sarcoma	0.000223	0.00741	CbGeAlD
Docetaxel—TUBB6—myometrium—sarcoma	0.000221	0.00736	CbGeAlD
Docetaxel—TUBB1—bone marrow—sarcoma	0.000218	0.00726	CbGeAlD
Docetaxel—TUBB2B—seminal vesicle—sarcoma	0.000215	0.00716	CbGeAlD
Docetaxel—CYP1B1—mammary gland—sarcoma	0.000215	0.00714	CbGeAlD
Docetaxel—TUBB4A—hematopoietic system—sarcoma	0.000212	0.00704	CbGeAlD
Docetaxel—MAP2—cardiac atrium—sarcoma	0.000208	0.00692	CbGeAlD
Docetaxel—TUBB4A—connective tissue—sarcoma	0.000204	0.00678	CbGeAlD
Docetaxel—TUBB—seminal vesicle—sarcoma	0.000204	0.00678	CbGeAlD
Docetaxel—BCL2—bone marrow—sarcoma	0.000203	0.00675	CbGeAlD
Docetaxel—TUBB2A—seminal vesicle—sarcoma	0.000203	0.00674	CbGeAlD
Docetaxel—TUBB6—seminal vesicle—sarcoma	0.0002	0.00665	CbGeAlD
Docetaxel—TUBB2B—connective tissue—sarcoma	0.000197	0.00656	CbGeAlD
Docetaxel—ABCC10—myometrium—sarcoma	0.000194	0.00645	CbGeAlD
Docetaxel—TUBB2A—hematopoietic system—sarcoma	0.000193	0.00641	CbGeAlD
Docetaxel—TUBB4B—myometrium—sarcoma	0.000192	0.0064	CbGeAlD
Docetaxel—TUBB3—testis—sarcoma	0.000191	0.00634	CbGeAlD
Docetaxel—MAP4—testis—sarcoma	0.000191	0.00634	CbGeAlD
Docetaxel—TUBB6—hematopoietic system—sarcoma	0.00019	0.00632	CbGeAlD
Docetaxel—TUBB1—testis—sarcoma	0.000187	0.0062	CbGeAlD
Docetaxel—TUBB2A—connective tissue—sarcoma	0.000186	0.00617	CbGeAlD
Docetaxel—TUBB4B—embryo—sarcoma	0.000185	0.00616	CbGeAlD
Docetaxel—TUBB4A—skin of body—sarcoma	0.000184	0.00613	CbGeAlD
Docetaxel—MAP2—tendon—sarcoma	0.000181	0.00603	CbGeAlD
Docetaxel—MAP4—liver—sarcoma	0.00018	0.006	CbGeAlD
Docetaxel—MAPT—lymph node—sarcoma	0.000176	0.00585	CbGeAlD
Docetaxel—ABCC10—seminal vesicle—sarcoma	0.000175	0.00582	CbGeAlD
Docetaxel—TUBB4B—seminal vesicle—sarcoma	0.000174	0.00578	CbGeAlD
Docetaxel—BCL2—testis—sarcoma	0.000173	0.00577	CbGeAlD
Docetaxel—EGFR—testis—sarcoma	0.000171	0.0057	CbGeAlD
Docetaxel—TUBB—smooth muscle tissue—sarcoma	0.000171	0.00568	CbGeAlD
Docetaxel—TUBB2A—smooth muscle tissue—sarcoma	0.00017	0.00565	CbGeAlD
Docetaxel—TUBB2A—skin of body—sarcoma	0.000168	0.00557	CbGeAlD
Docetaxel—TUBB6—smooth muscle tissue—sarcoma	0.000167	0.00557	CbGeAlD
Docetaxel—ABCC10—hematopoietic system—sarcoma	0.000166	0.00553	CbGeAlD
Docetaxel—TUBB6—skin of body—sarcoma	0.000165	0.0055	CbGeAlD
Docetaxel—TUBB4B—hematopoietic system—sarcoma	0.000165	0.0055	CbGeAlD
Docetaxel—EGFR—liver—sarcoma	0.000162	0.00539	CbGeAlD
Docetaxel—TUBB4A—uterus—sarcoma	0.00016	0.00532	CbGeAlD
Docetaxel—TUBB4B—connective tissue—sarcoma	0.000159	0.00529	CbGeAlD
Docetaxel—SLCO1B3—liver—sarcoma	0.000158	0.00525	CbGeAlD
Docetaxel—TUBB2B—cardiac atrium—sarcoma	0.000156	0.00517	CbGeAlD
Docetaxel—MAP2—testis—sarcoma	0.00015	0.005	CbGeAlD
Docetaxel—TUBB4A—lymphoid tissue—sarcoma	0.000149	0.00496	CbGeAlD
Docetaxel—TUBB—cardiac atrium—sarcoma	0.000147	0.00489	CbGeAlD
Docetaxel—TUBB—uterus—sarcoma	0.000146	0.00487	CbGeAlD
Docetaxel—TUBB2A—cardiac atrium—sarcoma	0.000146	0.00487	CbGeAlD
Docetaxel—TUBB2A—uterus—sarcoma	0.000146	0.00484	CbGeAlD
Docetaxel—TUBB4B—smooth muscle tissue—sarcoma	0.000146	0.00484	CbGeAlD
Docetaxel—TUBB6—cardiac atrium—sarcoma	0.000144	0.0048	CbGeAlD
Docetaxel—TUBB4B—skin of body—sarcoma	0.000144	0.00478	CbGeAlD
Docetaxel—TUBB6—uterus—sarcoma	0.000144	0.00478	CbGeAlD
Docetaxel—MAP2—liver—sarcoma	0.000142	0.00472	CbGeAlD
Docetaxel—TUBB4A—tendon—sarcoma	0.00014	0.00466	CbGeAlD
Docetaxel—MAP4—lymph node—sarcoma	0.000138	0.0046	CbGeAlD
Docetaxel—ABCC1—myometrium—sarcoma	0.000137	0.00456	CbGeAlD
Docetaxel—TUBB2B—tendon—sarcoma	0.000136	0.00451	CbGeAlD
Docetaxel—TUBB6—lymphoid tissue—sarcoma	0.000134	0.00445	CbGeAlD
Docetaxel—CYP3A7—liver—sarcoma	0.000133	0.00443	CbGeAlD
Docetaxel—CYP1B1—hematopoietic system—sarcoma	0.000131	0.00435	CbGeAlD
Docetaxel—SLC22A7—testis—sarcoma	0.00013	0.00432	CbGeAlD
Docetaxel—TUBB—tendon—sarcoma	0.000128	0.00426	CbGeAlD
Docetaxel—TUBB2A—tendon—sarcoma	0.000128	0.00424	CbGeAlD
Docetaxel—ABCC10—cardiac atrium—sarcoma	0.000126	0.0042	CbGeAlD
Docetaxel—CYP1B1—connective tissue—sarcoma	0.000126	0.00419	CbGeAlD
Docetaxel—TUBB6—tendon—sarcoma	0.000126	0.00418	CbGeAlD
Docetaxel—ABCC10—uterus—sarcoma	0.000126	0.00418	CbGeAlD
Docetaxel—BCL2—lymph node—sarcoma	0.000126	0.00418	CbGeAlD
Docetaxel—TUBB4B—cardiac atrium—sarcoma	0.000125	0.00417	CbGeAlD
Docetaxel—TUBB4B—uterus—sarcoma	0.000125	0.00415	CbGeAlD
Docetaxel—EGFR—lymph node—sarcoma	0.000124	0.00413	CbGeAlD
Docetaxel—TUBB—bone marrow—sarcoma	0.000124	0.00413	CbGeAlD
Docetaxel—ABCC1—seminal vesicle—sarcoma	0.000124	0.00412	CbGeAlD
Docetaxel—TUBB2A—bone marrow—sarcoma	0.000124	0.00411	CbGeAlD
Docetaxel—SLC22A7—liver—sarcoma	0.000123	0.00408	CbGeAlD
Docetaxel—TUBB6—bone marrow—sarcoma	0.000122	0.00405	CbGeAlD
Docetaxel—ABCC10—lymphoid tissue—sarcoma	0.000117	0.0039	CbGeAlD
Docetaxel—TUBB4B—lymphoid tissue—sarcoma	0.000116	0.00387	CbGeAlD
Docetaxel—TUBB4A—testis—sarcoma	0.000116	0.00386	CbGeAlD
Docetaxel—CYP1B1—smooth muscle tissue—sarcoma	0.000115	0.00383	CbGeAlD
Docetaxel—CYP1B1—skin of body—sarcoma	0.000114	0.00378	CbGeAlD
Docetaxel—ABCG2—myometrium—sarcoma	0.000114	0.00377	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—liver—sarcoma	0.000113	0.00377	CbGeAlD
Docetaxel—TUBB2B—testis—sarcoma	0.000112	0.00373	CbGeAlD
Docetaxel—ABCC10—tendon—sarcoma	0.00011	0.00366	CbGeAlD
Docetaxel—TUBB4A—liver—sarcoma	0.00011	0.00365	CbGeAlD
Docetaxel—TUBB4B—tendon—sarcoma	0.000109	0.00364	CbGeAlD
Docetaxel—MAP2—lymph node—sarcoma	0.000109	0.00362	CbGeAlD
Docetaxel—ABCC10—bone marrow—sarcoma	0.000107	0.00355	CbGeAlD
Docetaxel—TUBB—testis—sarcoma	0.000106	0.00353	CbGeAlD
Docetaxel—TUBB4B—bone marrow—sarcoma	0.000106	0.00352	CbGeAlD
Docetaxel—TUBB2A—testis—sarcoma	0.000106	0.00351	CbGeAlD
Docetaxel—TUBB6—testis—sarcoma	0.000104	0.00346	CbGeAlD
Docetaxel—ABCG2—seminal vesicle—sarcoma	0.000103	0.00341	CbGeAlD
Docetaxel—TUBB—liver—sarcoma	0.0001	0.00334	CbGeAlD
Docetaxel—TUBB2A—liver—sarcoma	9.99e-05	0.00332	CbGeAlD
Docetaxel—CYP1B1—uterus—sarcoma	9.89e-05	0.00329	CbGeAlD
Docetaxel—TUBB6—liver—sarcoma	9.85e-05	0.00328	CbGeAlD
Docetaxel—CYP1B1—lymphoid tissue—sarcoma	9.22e-05	0.00306	CbGeAlD
Docetaxel—ABCC10—testis—sarcoma	9.12e-05	0.00303	CbGeAlD
Docetaxel—TUBB4B—testis—sarcoma	9.06e-05	0.00301	CbGeAlD
Docetaxel—CYP3A5—hematopoietic system—sarcoma	9.05e-05	0.00301	CbGeAlD
Docetaxel—ABCC1—cardiac atrium—sarcoma	8.94e-05	0.00297	CbGeAlD
Docetaxel—ABCC1—uterus—sarcoma	8.89e-05	0.00296	CbGeAlD
Docetaxel—ABCC2—tendon—sarcoma	8.85e-05	0.00294	CbGeAlD
Docetaxel—CYP1B1—tendon—sarcoma	8.66e-05	0.00288	CbGeAlD
Docetaxel—ABCC10—liver—sarcoma	8.63e-05	0.00287	CbGeAlD
Docetaxel—TUBB4B—liver—sarcoma	8.56e-05	0.00285	CbGeAlD
Docetaxel—TUBB4A—lymph node—sarcoma	8.42e-05	0.0028	CbGeAlD
Docetaxel—TUBB2B—lymph node—sarcoma	8.14e-05	0.0027	CbGeAlD
Docetaxel—ABCC1—tendon—sarcoma	7.79e-05	0.00259	CbGeAlD
Docetaxel—TUBB—lymph node—sarcoma	7.7e-05	0.00256	CbGeAlD
Docetaxel—TUBB2A—lymph node—sarcoma	7.66e-05	0.00255	CbGeAlD
Docetaxel—TUBB6—lymph node—sarcoma	7.55e-05	0.00251	CbGeAlD
Docetaxel—ABCG2—uterus—sarcoma	7.36e-05	0.00245	CbGeAlD
Docetaxel—ABCC2—testis—sarcoma	7.33e-05	0.00244	CbGeAlD
Docetaxel—CYP1B1—testis—sarcoma	7.17e-05	0.00239	CbGeAlD
Docetaxel—ABCC2—liver—sarcoma	6.93e-05	0.0023	CbGeAlD
Docetaxel—CYP3A4—hematopoietic system—sarcoma	6.79e-05	0.00226	CbGeAlD
Docetaxel—CYP1B1—liver—sarcoma	6.78e-05	0.00225	CbGeAlD
Docetaxel—ABCC10—lymph node—sarcoma	6.61e-05	0.0022	CbGeAlD
Docetaxel—TUBB4B—lymph node—sarcoma	6.57e-05	0.00218	CbGeAlD
Docetaxel—ABCC1—testis—sarcoma	6.45e-05	0.00215	CbGeAlD
Docetaxel—ABCG2—bone marrow—sarcoma	6.25e-05	0.00208	CbGeAlD
Docetaxel—ABCC1—liver—sarcoma	6.1e-05	0.00203	CbGeAlD
Docetaxel—ABCB1—myometrium—sarcoma	5.6e-05	0.00186	CbGeAlD
Docetaxel—ABCB1—embryo—sarcoma	5.38e-05	0.00179	CbGeAlD
Docetaxel—ABCG2—testis—sarcoma	5.34e-05	0.00178	CbGeAlD
Docetaxel—ABCC2—lymph node—sarcoma	5.31e-05	0.00177	CbGeAlD
Docetaxel—CYP1B1—lymph node—sarcoma	5.2e-05	0.00173	CbGeAlD
Docetaxel—ABCB1—seminal vesicle—sarcoma	5.06e-05	0.00168	CbGeAlD
Docetaxel—ABCG2—liver—sarcoma	5.05e-05	0.00168	CbGeAlD
Docetaxel—ABCB1—hematopoietic system—sarcoma	4.81e-05	0.0016	CbGeAlD
Docetaxel—CYP3A5—liver—sarcoma	4.69e-05	0.00156	CbGeAlD
Docetaxel—ABCC1—lymph node—sarcoma	4.68e-05	0.00156	CbGeAlD
Docetaxel—ABCG2—lymph node—sarcoma	3.87e-05	0.00129	CbGeAlD
Docetaxel—ABCB1—uterus—sarcoma	3.63e-05	0.00121	CbGeAlD
Docetaxel—CYP3A4—liver—sarcoma	3.52e-05	0.00117	CbGeAlD
Docetaxel—ABCB1—lymphoid tissue—sarcoma	3.38e-05	0.00113	CbGeAlD
Docetaxel—Skin disorder—Etoposide—sarcoma	3.34e-05	0.000464	CcSEcCtD
Docetaxel—Dry skin—Doxorubicin—sarcoma	3.33e-05	0.000462	CcSEcCtD
Docetaxel—Orthostatic hypotension—Doxorubicin—sarcoma	3.32e-05	0.00046	CcSEcCtD
Docetaxel—Abdominal pain upper—Doxorubicin—sarcoma	3.32e-05	0.00046	CcSEcCtD
Docetaxel—Angina pectoris—Epirubicin—sarcoma	3.31e-05	0.000459	CcSEcCtD
Docetaxel—Breast disorder—Doxorubicin—sarcoma	3.28e-05	0.000455	CcSEcCtD
Docetaxel—Anorexia—Etoposide—sarcoma	3.28e-05	0.000455	CcSEcCtD
Docetaxel—Diarrhoea—Thiotepa—sarcoma	3.28e-05	0.000455	CcSEcCtD
Docetaxel—Abdominal pain—Mitoxantrone—sarcoma	3.27e-05	0.000454	CcSEcCtD
Docetaxel—Body temperature increased—Mitoxantrone—sarcoma	3.27e-05	0.000454	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Doxorubicin—sarcoma	3.27e-05	0.000454	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Doxorubicin—sarcoma	3.27e-05	0.000454	CcSEcCtD
Docetaxel—Diarrhoea—Dactinomycin—sarcoma	3.25e-05	0.000452	CcSEcCtD
Docetaxel—Nasopharyngitis—Doxorubicin—sarcoma	3.25e-05	0.000451	CcSEcCtD
Docetaxel—Pancytopenia—Epirubicin—sarcoma	3.22e-05	0.000447	CcSEcCtD
Docetaxel—Hypotension—Etoposide—sarcoma	3.22e-05	0.000446	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Doxorubicin—sarcoma	3.2e-05	0.000445	CcSEcCtD
Docetaxel—Neutropenia—Epirubicin—sarcoma	3.17e-05	0.00044	CcSEcCtD
Docetaxel—Dizziness—Thiotepa—sarcoma	3.17e-05	0.00044	CcSEcCtD
Docetaxel—Dysphagia—Doxorubicin—sarcoma	3.14e-05	0.000436	CcSEcCtD
Docetaxel—Hypersensitivity—Vincristine—sarcoma	3.13e-05	0.000434	CcSEcCtD
Docetaxel—Paraesthesia—Etoposide—sarcoma	3.09e-05	0.000429	CcSEcCtD
Docetaxel—Weight increased—Epirubicin—sarcoma	3.09e-05	0.000428	CcSEcCtD
Docetaxel—ABCB1—bone marrow—sarcoma	3.08e-05	0.00102	CbGeAlD
Docetaxel—Weight decreased—Epirubicin—sarcoma	3.07e-05	0.000426	CcSEcCtD
Docetaxel—Dyspnoea—Etoposide—sarcoma	3.07e-05	0.000426	CcSEcCtD
Docetaxel—Somnolence—Etoposide—sarcoma	3.06e-05	0.000425	CcSEcCtD
Docetaxel—Angina pectoris—Doxorubicin—sarcoma	3.06e-05	0.000424	CcSEcCtD
Docetaxel—Hypersensitivity—Mitoxantrone—sarcoma	3.05e-05	0.000423	CcSEcCtD
Docetaxel—Asthenia—Vincristine—sarcoma	3.05e-05	0.000423	CcSEcCtD
Docetaxel—Vomiting—Thiotepa—sarcoma	3.05e-05	0.000423	CcSEcCtD
Docetaxel—Pneumonia—Epirubicin—sarcoma	3.04e-05	0.000422	CcSEcCtD
Docetaxel—Infestation NOS—Epirubicin—sarcoma	3.03e-05	0.00042	CcSEcCtD
Docetaxel—Infestation—Epirubicin—sarcoma	3.03e-05	0.00042	CcSEcCtD
Docetaxel—Vomiting—Dactinomycin—sarcoma	3.02e-05	0.00042	CcSEcCtD
Docetaxel—Rash—Thiotepa—sarcoma	3.02e-05	0.000419	CcSEcCtD
Docetaxel—Dermatitis—Thiotepa—sarcoma	3.02e-05	0.000419	CcSEcCtD
Docetaxel—Headache—Thiotepa—sarcoma	3e-05	0.000417	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Epirubicin—sarcoma	3e-05	0.000416	CcSEcCtD
Docetaxel—Rash—Dactinomycin—sarcoma	3e-05	0.000416	CcSEcCtD
Docetaxel—Decreased appetite—Etoposide—sarcoma	2.99e-05	0.000415	CcSEcCtD
Docetaxel—Pancytopenia—Doxorubicin—sarcoma	2.98e-05	0.000414	CcSEcCtD
Docetaxel—Renal failure—Epirubicin—sarcoma	2.97e-05	0.000413	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Etoposide—sarcoma	2.97e-05	0.000412	CcSEcCtD
Docetaxel—Asthenia—Mitoxantrone—sarcoma	2.97e-05	0.000412	CcSEcCtD
Docetaxel—Fatigue—Etoposide—sarcoma	2.97e-05	0.000412	CcSEcCtD
Docetaxel—Neuropathy peripheral—Epirubicin—sarcoma	2.97e-05	0.000411	CcSEcCtD
Docetaxel—Jaundice—Epirubicin—sarcoma	2.95e-05	0.000409	CcSEcCtD
Docetaxel—Stomatitis—Epirubicin—sarcoma	2.95e-05	0.000409	CcSEcCtD
Docetaxel—Constipation—Etoposide—sarcoma	2.94e-05	0.000408	CcSEcCtD
Docetaxel—Pain—Etoposide—sarcoma	2.94e-05	0.000408	CcSEcCtD
Docetaxel—Conjunctivitis—Epirubicin—sarcoma	2.94e-05	0.000408	CcSEcCtD
Docetaxel—Neutropenia—Doxorubicin—sarcoma	2.94e-05	0.000407	CcSEcCtD
Docetaxel—Diarrhoea—Vincristine—sarcoma	2.91e-05	0.000403	CcSEcCtD
Docetaxel—Hepatobiliary disease—Epirubicin—sarcoma	2.86e-05	0.000397	CcSEcCtD
Docetaxel—Weight increased—Doxorubicin—sarcoma	2.86e-05	0.000396	CcSEcCtD
Docetaxel—Epistaxis—Epirubicin—sarcoma	2.85e-05	0.000396	CcSEcCtD
Docetaxel—Nausea—Thiotepa—sarcoma	2.85e-05	0.000395	CcSEcCtD
Docetaxel—Weight decreased—Doxorubicin—sarcoma	2.84e-05	0.000394	CcSEcCtD
Docetaxel—Feeling abnormal—Etoposide—sarcoma	2.84e-05	0.000394	CcSEcCtD
Docetaxel—Diarrhoea—Mitoxantrone—sarcoma	2.83e-05	0.000393	CcSEcCtD
Docetaxel—Nausea—Dactinomycin—sarcoma	2.82e-05	0.000392	CcSEcCtD
Docetaxel—Agranulocytosis—Epirubicin—sarcoma	2.82e-05	0.000392	CcSEcCtD
Docetaxel—Pneumonia—Doxorubicin—sarcoma	2.82e-05	0.000391	CcSEcCtD
Docetaxel—Gastrointestinal pain—Etoposide—sarcoma	2.81e-05	0.000391	CcSEcCtD
Docetaxel—Dizziness—Vincristine—sarcoma	2.81e-05	0.00039	CcSEcCtD
Docetaxel—Infestation—Doxorubicin—sarcoma	2.8e-05	0.000388	CcSEcCtD
Docetaxel—Infestation NOS—Doxorubicin—sarcoma	2.8e-05	0.000388	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—sarcoma	2.78e-05	0.000385	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—sarcoma	2.75e-05	0.000382	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—sarcoma	2.74e-05	0.000381	CcSEcCtD
Docetaxel—Haemoglobin—Epirubicin—sarcoma	2.73e-05	0.000379	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—sarcoma	2.73e-05	0.000379	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—sarcoma	2.73e-05	0.000379	CcSEcCtD
Docetaxel—Rhinitis—Epirubicin—sarcoma	2.72e-05	0.000378	CcSEcCtD
Docetaxel—Abdominal pain—Etoposide—sarcoma	2.72e-05	0.000378	CcSEcCtD
Docetaxel—Body temperature increased—Etoposide—sarcoma	2.72e-05	0.000378	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—sarcoma	2.72e-05	0.000378	CcSEcCtD
Docetaxel—Haemorrhage—Epirubicin—sarcoma	2.72e-05	0.000377	CcSEcCtD
Docetaxel—Hepatitis—Epirubicin—sarcoma	2.72e-05	0.000377	CcSEcCtD
Docetaxel—Hypoaesthesia—Epirubicin—sarcoma	2.7e-05	0.000375	CcSEcCtD
Docetaxel—Vomiting—Vincristine—sarcoma	2.7e-05	0.000375	CcSEcCtD
Docetaxel—Pharyngitis—Epirubicin—sarcoma	2.7e-05	0.000374	CcSEcCtD
Docetaxel—Urinary tract disorder—Epirubicin—sarcoma	2.68e-05	0.000372	CcSEcCtD
Docetaxel—Rash—Vincristine—sarcoma	2.68e-05	0.000372	CcSEcCtD
Docetaxel—Dermatitis—Vincristine—sarcoma	2.68e-05	0.000371	CcSEcCtD
Docetaxel—Oedema peripheral—Epirubicin—sarcoma	2.68e-05	0.000371	CcSEcCtD
Docetaxel—Connective tissue disorder—Epirubicin—sarcoma	2.67e-05	0.00037	CcSEcCtD
Docetaxel—Urethral disorder—Epirubicin—sarcoma	2.66e-05	0.000369	CcSEcCtD
Docetaxel—Headache—Vincristine—sarcoma	2.66e-05	0.000369	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—sarcoma	2.65e-05	0.000367	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—sarcoma	2.64e-05	0.000366	CcSEcCtD
Docetaxel—ABCB1—testis—sarcoma	2.63e-05	0.000876	CbGeAlD
Docetaxel—Vomiting—Mitoxantrone—sarcoma	2.63e-05	0.000365	CcSEcCtD
Docetaxel—Visual impairment—Epirubicin—sarcoma	2.62e-05	0.000363	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—sarcoma	2.61e-05	0.000362	CcSEcCtD
Docetaxel—Rash—Mitoxantrone—sarcoma	2.61e-05	0.000362	CcSEcCtD
Docetaxel—Dermatitis—Mitoxantrone—sarcoma	2.61e-05	0.000362	CcSEcCtD
Docetaxel—Headache—Mitoxantrone—sarcoma	2.59e-05	0.00036	CcSEcCtD
Docetaxel—Erythema multiforme—Epirubicin—sarcoma	2.57e-05	0.000356	CcSEcCtD
Docetaxel—Eye disorder—Epirubicin—sarcoma	2.54e-05	0.000352	CcSEcCtD
Docetaxel—Hypersensitivity—Etoposide—sarcoma	2.54e-05	0.000352	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—sarcoma	2.53e-05	0.00035	CcSEcCtD
Docetaxel—Nausea—Vincristine—sarcoma	2.52e-05	0.00035	CcSEcCtD
Docetaxel—Flushing—Epirubicin—sarcoma	2.52e-05	0.00035	CcSEcCtD
Docetaxel—Cardiac disorder—Epirubicin—sarcoma	2.52e-05	0.00035	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—sarcoma	2.52e-05	0.00035	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—sarcoma	2.51e-05	0.000349	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—sarcoma	2.51e-05	0.000349	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—sarcoma	2.5e-05	0.000347	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—sarcoma	2.49e-05	0.000346	CcSEcCtD
Docetaxel—ABCB1—liver—sarcoma	2.49e-05	0.000828	CbGeAlD
Docetaxel—Urinary tract disorder—Doxorubicin—sarcoma	2.48e-05	0.000344	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—sarcoma	2.48e-05	0.000343	CcSEcCtD
Docetaxel—Asthenia—Etoposide—sarcoma	2.47e-05	0.000343	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—sarcoma	2.47e-05	0.000343	CcSEcCtD
Docetaxel—Angiopathy—Epirubicin—sarcoma	2.46e-05	0.000342	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—sarcoma	2.46e-05	0.000342	CcSEcCtD
Docetaxel—Nausea—Mitoxantrone—sarcoma	2.46e-05	0.000341	CcSEcCtD
Docetaxel—Immune system disorder—Epirubicin—sarcoma	2.45e-05	0.00034	CcSEcCtD
Docetaxel—Mediastinal disorder—Epirubicin—sarcoma	2.45e-05	0.00034	CcSEcCtD
Docetaxel—Chills—Epirubicin—sarcoma	2.44e-05	0.000338	CcSEcCtD
Docetaxel—Pruritus—Etoposide—sarcoma	2.44e-05	0.000338	CcSEcCtD
Docetaxel—Arrhythmia—Epirubicin—sarcoma	2.43e-05	0.000337	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—sarcoma	2.42e-05	0.000336	CcSEcCtD
Docetaxel—Alopecia—Epirubicin—sarcoma	2.4e-05	0.000333	CcSEcCtD
Docetaxel—Mental disorder—Epirubicin—sarcoma	2.38e-05	0.00033	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—sarcoma	2.38e-05	0.00033	CcSEcCtD
Docetaxel—Erythema—Epirubicin—sarcoma	2.36e-05	0.000328	CcSEcCtD
Docetaxel—Malnutrition—Epirubicin—sarcoma	2.36e-05	0.000328	CcSEcCtD
Docetaxel—Diarrhoea—Etoposide—sarcoma	2.36e-05	0.000327	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—sarcoma	2.35e-05	0.000326	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—sarcoma	2.33e-05	0.000324	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—sarcoma	2.33e-05	0.000324	CcSEcCtD
Docetaxel—Dysgeusia—Epirubicin—sarcoma	2.32e-05	0.000321	CcSEcCtD
Docetaxel—Back pain—Epirubicin—sarcoma	2.29e-05	0.000317	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—sarcoma	2.28e-05	0.000316	CcSEcCtD
Docetaxel—Dizziness—Etoposide—sarcoma	2.28e-05	0.000316	CcSEcCtD
Docetaxel—Muscle spasms—Epirubicin—sarcoma	2.27e-05	0.000315	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—sarcoma	2.27e-05	0.000315	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—sarcoma	2.26e-05	0.000314	CcSEcCtD
Docetaxel—Chills—Doxorubicin—sarcoma	2.25e-05	0.000313	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—sarcoma	2.24e-05	0.000311	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—sarcoma	2.22e-05	0.000308	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—sarcoma	2.2e-05	0.000305	CcSEcCtD
Docetaxel—Vomiting—Etoposide—sarcoma	2.19e-05	0.000304	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—sarcoma	2.19e-05	0.000304	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—sarcoma	2.19e-05	0.000304	CcSEcCtD
Docetaxel—Anaemia—Epirubicin—sarcoma	2.19e-05	0.000303	CcSEcCtD
Docetaxel—Rash—Etoposide—sarcoma	2.17e-05	0.000301	CcSEcCtD
Docetaxel—Dermatitis—Etoposide—sarcoma	2.17e-05	0.000301	CcSEcCtD
Docetaxel—Headache—Etoposide—sarcoma	2.16e-05	0.000299	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—sarcoma	2.14e-05	0.000297	CcSEcCtD
Docetaxel—Syncope—Epirubicin—sarcoma	2.12e-05	0.000294	CcSEcCtD
Docetaxel—Leukopenia—Epirubicin—sarcoma	2.12e-05	0.000294	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—sarcoma	2.12e-05	0.000294	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—sarcoma	2.1e-05	0.000292	CcSEcCtD
Docetaxel—Palpitations—Epirubicin—sarcoma	2.09e-05	0.00029	CcSEcCtD
Docetaxel—Loss of consciousness—Epirubicin—sarcoma	2.08e-05	0.000288	CcSEcCtD
Docetaxel—Cough—Epirubicin—sarcoma	2.06e-05	0.000286	CcSEcCtD
Docetaxel—Convulsion—Epirubicin—sarcoma	2.05e-05	0.000284	CcSEcCtD
Docetaxel—Nausea—Etoposide—sarcoma	2.04e-05	0.000284	CcSEcCtD
Docetaxel—Hypertension—Epirubicin—sarcoma	2.04e-05	0.000283	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—sarcoma	2.02e-05	0.000281	CcSEcCtD
Docetaxel—Myalgia—Epirubicin—sarcoma	2.01e-05	0.000279	CcSEcCtD
Docetaxel—Arthralgia—Epirubicin—sarcoma	2.01e-05	0.000279	CcSEcCtD
Docetaxel—Chest pain—Epirubicin—sarcoma	2.01e-05	0.000279	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	2e-05	0.000277	CcSEcCtD
Docetaxel—Dry mouth—Epirubicin—sarcoma	1.97e-05	0.000273	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—sarcoma	1.96e-05	0.000272	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—sarcoma	1.96e-05	0.000272	CcSEcCtD
Docetaxel—Confusional state—Epirubicin—sarcoma	1.95e-05	0.00027	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—sarcoma	1.93e-05	0.000268	CcSEcCtD
Docetaxel—Oedema—Epirubicin—sarcoma	1.93e-05	0.000268	CcSEcCtD
Docetaxel—Anaphylactic shock—Epirubicin—sarcoma	1.93e-05	0.000268	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—sarcoma	1.92e-05	0.000267	CcSEcCtD
Docetaxel—Infection—Epirubicin—sarcoma	1.92e-05	0.000266	CcSEcCtD
Docetaxel—ABCB1—lymph node—sarcoma	1.91e-05	0.000635	CbGeAlD
Docetaxel—Cough—Doxorubicin—sarcoma	1.91e-05	0.000265	CcSEcCtD
Docetaxel—Shock—Epirubicin—sarcoma	1.9e-05	0.000263	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—sarcoma	1.9e-05	0.000263	CcSEcCtD
Docetaxel—Nervous system disorder—Epirubicin—sarcoma	1.89e-05	0.000263	CcSEcCtD
Docetaxel—Thrombocytopenia—Epirubicin—sarcoma	1.89e-05	0.000262	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—sarcoma	1.89e-05	0.000262	CcSEcCtD
Docetaxel—Tachycardia—Epirubicin—sarcoma	1.88e-05	0.000261	CcSEcCtD
Docetaxel—Skin disorder—Epirubicin—sarcoma	1.87e-05	0.00026	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—sarcoma	1.86e-05	0.000258	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—sarcoma	1.86e-05	0.000258	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—sarcoma	1.86e-05	0.000258	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	1.85e-05	0.000257	CcSEcCtD
Docetaxel—Anorexia—Epirubicin—sarcoma	1.84e-05	0.000255	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—sarcoma	1.82e-05	0.000253	CcSEcCtD
Docetaxel—Hypotension—Epirubicin—sarcoma	1.8e-05	0.00025	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—sarcoma	1.8e-05	0.00025	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—sarcoma	1.79e-05	0.000248	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—sarcoma	1.79e-05	0.000248	CcSEcCtD
Docetaxel—Infection—Doxorubicin—sarcoma	1.77e-05	0.000246	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Epirubicin—sarcoma	1.76e-05	0.000244	CcSEcCtD
Docetaxel—Shock—Doxorubicin—sarcoma	1.76e-05	0.000244	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—sarcoma	1.75e-05	0.000243	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—sarcoma	1.75e-05	0.000243	CcSEcCtD
Docetaxel—Insomnia—Epirubicin—sarcoma	1.75e-05	0.000242	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—sarcoma	1.74e-05	0.000242	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—sarcoma	1.73e-05	0.000241	CcSEcCtD
Docetaxel—Paraesthesia—Epirubicin—sarcoma	1.73e-05	0.00024	CcSEcCtD
Docetaxel—Dyspnoea—Epirubicin—sarcoma	1.72e-05	0.000239	CcSEcCtD
Docetaxel—Somnolence—Epirubicin—sarcoma	1.72e-05	0.000238	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—sarcoma	1.7e-05	0.000236	CcSEcCtD
Docetaxel—Dyspepsia—Epirubicin—sarcoma	1.7e-05	0.000236	CcSEcCtD
Docetaxel—Decreased appetite—Epirubicin—sarcoma	1.68e-05	0.000233	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—sarcoma	1.67e-05	0.000231	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Epirubicin—sarcoma	1.67e-05	0.000231	CcSEcCtD
Docetaxel—Fatigue—Epirubicin—sarcoma	1.66e-05	0.000231	CcSEcCtD
Docetaxel—Constipation—Epirubicin—sarcoma	1.65e-05	0.000229	CcSEcCtD
Docetaxel—Pain—Epirubicin—sarcoma	1.65e-05	0.000229	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—sarcoma	1.63e-05	0.000226	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—sarcoma	1.61e-05	0.000224	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—sarcoma	1.6e-05	0.000222	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—sarcoma	1.59e-05	0.000221	CcSEcCtD
Docetaxel—Feeling abnormal—Epirubicin—sarcoma	1.59e-05	0.000221	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—sarcoma	1.59e-05	0.00022	CcSEcCtD
Docetaxel—Gastrointestinal pain—Epirubicin—sarcoma	1.58e-05	0.000219	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—sarcoma	1.57e-05	0.000218	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—sarcoma	1.55e-05	0.000215	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—sarcoma	1.54e-05	0.000214	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—sarcoma	1.54e-05	0.000214	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—sarcoma	1.53e-05	0.000212	CcSEcCtD
Docetaxel—Pain—Doxorubicin—sarcoma	1.53e-05	0.000212	CcSEcCtD
Docetaxel—Abdominal pain—Epirubicin—sarcoma	1.53e-05	0.000212	CcSEcCtD
Docetaxel—Body temperature increased—Epirubicin—sarcoma	1.53e-05	0.000212	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—sarcoma	1.47e-05	0.000204	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—sarcoma	1.46e-05	0.000203	CcSEcCtD
Docetaxel—Hypersensitivity—Epirubicin—sarcoma	1.42e-05	0.000197	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—sarcoma	1.41e-05	0.000196	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—sarcoma	1.41e-05	0.000196	CcSEcCtD
Docetaxel—Asthenia—Epirubicin—sarcoma	1.38e-05	0.000192	CcSEcCtD
Docetaxel—Pruritus—Epirubicin—sarcoma	1.37e-05	0.000189	CcSEcCtD
Docetaxel—Diarrhoea—Epirubicin—sarcoma	1.32e-05	0.000183	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—sarcoma	1.32e-05	0.000183	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—sarcoma	1.28e-05	0.000178	CcSEcCtD
Docetaxel—Dizziness—Epirubicin—sarcoma	1.28e-05	0.000177	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—sarcoma	1.26e-05	0.000175	CcSEcCtD
Docetaxel—Vomiting—Epirubicin—sarcoma	1.23e-05	0.00017	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—sarcoma	1.22e-05	0.000169	CcSEcCtD
Docetaxel—Rash—Epirubicin—sarcoma	1.22e-05	0.000169	CcSEcCtD
Docetaxel—Dermatitis—Epirubicin—sarcoma	1.22e-05	0.000169	CcSEcCtD
Docetaxel—Headache—Epirubicin—sarcoma	1.21e-05	0.000168	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—sarcoma	1.18e-05	0.000164	CcSEcCtD
Docetaxel—Nausea—Epirubicin—sarcoma	1.15e-05	0.000159	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—sarcoma	1.14e-05	0.000158	CcSEcCtD
Docetaxel—Rash—Doxorubicin—sarcoma	1.13e-05	0.000156	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—sarcoma	1.12e-05	0.000156	CcSEcCtD
Docetaxel—Headache—Doxorubicin—sarcoma	1.12e-05	0.000155	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—sarcoma	1.06e-05	0.000147	CcSEcCtD
Docetaxel—EGFR—B Cell Activation—NRAS—sarcoma	9.21e-06	0.000249	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—MMP2—sarcoma	9.2e-06	0.000249	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MMP2—sarcoma	9.2e-06	0.000249	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—KRAS—sarcoma	9.19e-06	0.000248	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—KRAS—sarcoma	9.19e-06	0.000248	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—sarcoma	9.18e-06	0.000248	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—SRC—sarcoma	9.16e-06	0.000247	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—KRAS—sarcoma	9.15e-06	0.000247	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—KRAS—sarcoma	9.1e-06	0.000246	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—MDM2—sarcoma	9.04e-06	0.000244	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MDM2—sarcoma	8.97e-06	0.000242	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—sarcoma	8.97e-06	0.000242	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—KRAS—sarcoma	8.93e-06	0.000241	CbGpPWpGaD
Docetaxel—EGFR—Disease—NPM1—sarcoma	8.86e-06	0.000239	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—sarcoma	8.81e-06	0.000238	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—sarcoma	8.74e-06	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—HRAS—sarcoma	8.73e-06	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	8.72e-06	0.000236	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—MDM2—sarcoma	8.72e-06	0.000235	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—sarcoma	8.64e-06	0.000233	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CTNNB1—sarcoma	8.59e-06	0.000232	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CTNNB1—sarcoma	8.59e-06	0.000232	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—FOXO1—sarcoma	8.59e-06	0.000232	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PDGFRB—sarcoma	8.57e-06	0.000232	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	8.56e-06	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—KRAS—sarcoma	8.56e-06	0.000231	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—KRAS—sarcoma	8.56e-06	0.000231	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CCND1—sarcoma	8.55e-06	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	8.52e-06	0.00023	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—KRAS—sarcoma	8.49e-06	0.000229	CbGpPWpGaD
Docetaxel—BCL2—Immune System—FOXO1—sarcoma	8.46e-06	0.000229	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PDGFRB—sarcoma	8.45e-06	0.000228	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PDGFRA—sarcoma	8.44e-06	0.000228	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—MMP2—sarcoma	8.42e-06	0.000227	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—KRAS—sarcoma	8.41e-06	0.000227	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—KRAS—sarcoma	8.38e-06	0.000226	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—HRAS—sarcoma	8.35e-06	0.000226	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—SRC—sarcoma	8.33e-06	0.000225	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PDGFRA—sarcoma	8.32e-06	0.000225	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CTNNB1—sarcoma	8.3e-06	0.000224	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—MYC—sarcoma	8.27e-06	0.000223	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—FOXO1—sarcoma	8.25e-06	0.000223	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PDGFRB—sarcoma	8.23e-06	0.000222	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—HRAS—sarcoma	8.22e-06	0.000222	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PLCG1—sarcoma	8.18e-06	0.000221	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ENO2—sarcoma	8.14e-06	0.00022	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—VEGFA—sarcoma	8.11e-06	0.000219	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PDGFRA—sarcoma	8.11e-06	0.000219	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	8.06e-06	0.000218	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KDR—sarcoma	8.04e-06	0.000217	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CTNNB1—sarcoma	8.04e-06	0.000217	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NRAS—sarcoma	8.02e-06	0.000216	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—sarcoma	7.94e-06	0.000214	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—KRAS—sarcoma	7.93e-06	0.000214	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CTNNB1—sarcoma	7.86e-06	0.000212	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—HRAS—sarcoma	7.85e-06	0.000212	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CCND1—sarcoma	7.82e-06	0.000211	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—HRAS—sarcoma	7.81e-06	0.000211	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—HRAS—sarcoma	7.81e-06	0.000211	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—HRAS—sarcoma	7.78e-06	0.00021	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—HRAS—sarcoma	7.74e-06	0.000209	CbGpPWpGaD
Docetaxel—EGFR—Disease—ENO2—sarcoma	7.67e-06	0.000207	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—MYC—sarcoma	7.67e-06	0.000207	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	7.63e-06	0.000206	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	7.61e-06	0.000206	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	7.59e-06	0.000205	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—JUN—sarcoma	7.58e-06	0.000205	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CTNNB1—sarcoma	7.52e-06	0.000203	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MYC—sarcoma	7.47e-06	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCR4—sarcoma	7.41e-06	0.0002	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	7.33e-06	0.000198	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EGFR—sarcoma	7.3e-06	0.000197	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	7.28e-06	0.000197	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—sarcoma	7.28e-06	0.000197	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—sarcoma	7.28e-06	0.000197	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—sarcoma	7.21e-06	0.000195	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTPRC—sarcoma	7.2e-06	0.000195	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	7.16e-06	0.000193	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—sarcoma	7.15e-06	0.000193	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—sarcoma	7.12e-06	0.000192	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CTNNB1—sarcoma	7.06e-06	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CREB1—sarcoma	7.05e-06	0.00019	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PLCG1—sarcoma	7.05e-06	0.00019	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—SRC—sarcoma	7.05e-06	0.00019	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MYC—sarcoma	7.01e-06	0.000189	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PLCG1—sarcoma	6.91e-06	0.000187	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—KRAS—sarcoma	6.9e-06	0.000186	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—sarcoma	6.88e-06	0.000186	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TLE1—sarcoma	6.88e-06	0.000186	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MYC—sarcoma	6.86e-06	0.000185	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ENO2—sarcoma	6.82e-06	0.000184	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—SRC—sarcoma	6.8e-06	0.000184	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—sarcoma	6.79e-06	0.000183	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NRAS—sarcoma	6.78e-06	0.000183	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—HBA1—sarcoma	6.77e-06	0.000183	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—sarcoma	6.74e-06	0.000182	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ATF1—sarcoma	6.7e-06	0.000181	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CXCR4—sarcoma	6.64e-06	0.000179	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ENO2—sarcoma	6.59e-06	0.000178	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MMP2—sarcoma	6.57e-06	0.000177	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—HBA1—sarcoma	6.55e-06	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KIT—sarcoma	6.54e-06	0.000177	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NRAS—sarcoma	6.54e-06	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Disease—PLCG1—sarcoma	6.51e-06	0.000176	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CTNNB1—sarcoma	6.45e-06	0.000174	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KIT—sarcoma	6.45e-06	0.000174	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	6.45e-06	0.000174	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—SRC—sarcoma	6.38e-06	0.000172	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	6.3e-06	0.00017	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KIT—sarcoma	6.28e-06	0.00017	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MYC—sarcoma	6.27e-06	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Disease—CXCR4—sarcoma	6.25e-06	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	6.23e-06	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CREB1—sarcoma	6.23e-06	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—VEGFA—sarcoma	6.21e-06	0.000168	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CREB1—sarcoma	6.14e-06	0.000166	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—NRAS—sarcoma	6.13e-06	0.000166	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—sarcoma	6.13e-06	0.000166	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ENO2—sarcoma	6e-06	0.000162	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CREB1—sarcoma	5.98e-06	0.000162	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—HBA1—sarcoma	5.96e-06	0.000161	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—sarcoma	5.96e-06	0.000161	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ENO2—sarcoma	5.95e-06	0.000161	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—HBA1—sarcoma	5.91e-06	0.00016	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—sarcoma	5.86e-06	0.000158	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—KRAS—sarcoma	5.83e-06	0.000158	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFC—sarcoma	5.8e-06	0.000157	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PLCG1—sarcoma	5.78e-06	0.000156	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—sarcoma	5.63e-06	0.000152	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—KRAS—sarcoma	5.63e-06	0.000152	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—MYC—sarcoma	5.61e-06	0.000151	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PLCG1—sarcoma	5.59e-06	0.000151	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	5.49e-06	0.000148	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	5.48e-06	0.000148	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	5.43e-06	0.000147	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—KRAS—sarcoma	5.28e-06	0.000143	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MDM2—sarcoma	5.15e-06	0.000139	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—sarcoma	5.15e-06	0.000139	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PLCG1—sarcoma	5.09e-06	0.000137	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MDM2—sarcoma	5.08e-06	0.000137	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PLCG1—sarcoma	5.04e-06	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CTNNB1—sarcoma	5.03e-06	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FOXO1—sarcoma	5e-06	0.000135	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PDGFRB—sarcoma	4.99e-06	0.000135	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—sarcoma	4.96e-06	0.000134	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—MDM2—sarcoma	4.95e-06	0.000134	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PDGFRA—sarcoma	4.92e-06	0.000133	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	4.91e-06	0.000133	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FOXO1—sarcoma	4.9e-06	0.000132	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PDGFRB—sarcoma	4.89e-06	0.000132	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PDGFRA—sarcoma	4.82e-06	0.00013	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	4.78e-06	0.000129	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—sarcoma	4.78e-06	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FLT1—sarcoma	4.64e-06	0.000125	CbGpPWpGaD
Docetaxel—EGFR—Disease—FOXO1—sarcoma	4.62e-06	0.000125	CbGpPWpGaD
Docetaxel—EGFR—Disease—PDGFRB—sarcoma	4.61e-06	0.000125	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PLCG1—sarcoma	4.56e-06	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—SRC—sarcoma	4.55e-06	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Disease—PDGFRA—sarcoma	4.54e-06	0.000123	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2—sarcoma	4.54e-06	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—sarcoma	4.49e-06	0.000121	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—JUN—sarcoma	4.48e-06	0.000121	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTNNB1—sarcoma	4.45e-06	0.00012	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—sarcoma	4.43e-06	0.00012	CbGpPWpGaD
Docetaxel—BCL2—Immune System—JUN—sarcoma	4.41e-06	0.000119	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	4.4e-06	0.000119	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTNNB1—sarcoma	4.38e-06	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCR4—sarcoma	4.38e-06	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—sarcoma	4.38e-06	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ATF1—sarcoma	4.33e-06	0.000117	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	4.31e-06	0.000116	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ENO2—sarcoma	4.3e-06	0.000116	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HBA1—sarcoma	4.27e-06	0.000115	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.07e-06	0.00011	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—SRC—sarcoma	4.02e-06	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CREB1—sarcoma	3.97e-06	0.000107	CbGpPWpGaD
Docetaxel—BCL2—Immune System—SRC—sarcoma	3.96e-06	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—sarcoma	3.87e-06	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—SRC—sarcoma	3.86e-06	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KIT—sarcoma	3.81e-06	0.000103	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—sarcoma	3.81e-06	0.000103	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—sarcoma	3.77e-06	0.000102	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KIT—sarcoma	3.73e-06	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—sarcoma	3.71e-06	0.0001	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PLCG1—sarcoma	3.65e-06	9.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CREB1—sarcoma	3.63e-06	9.8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.62e-06	9.76e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CREB1—sarcoma	3.55e-06	9.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KIT—sarcoma	3.52e-06	9.5e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—sarcoma	3.47e-06	9.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1R—sarcoma	3.4e-06	9.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CREB1—sarcoma	3.35e-06	9.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—sarcoma	3.33e-06	8.99e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—sarcoma	3.28e-06	8.85e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ENO2—sarcoma	3.24e-06	8.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FOXO1—sarcoma	3.23e-06	8.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDGFRB—sarcoma	3.23e-06	8.72e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HBA1—sarcoma	3.22e-06	8.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—sarcoma	3.2e-06	8.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—sarcoma	3.2e-06	8.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDGFRA—sarcoma	3.18e-06	8.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MDM2—sarcoma	3e-06	8.11e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MDM2—sarcoma	2.94e-06	7.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—sarcoma	2.94e-06	7.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—sarcoma	2.83e-06	7.64e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—sarcoma	2.79e-06	7.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MDM2—sarcoma	2.77e-06	7.49e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PLCG1—sarcoma	2.75e-06	7.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—sarcoma	2.72e-06	7.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—sarcoma	2.68e-06	7.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—sarcoma	2.68e-06	7.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—JUN—sarcoma	2.61e-06	7.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—sarcoma	2.59e-06	6.99e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—sarcoma	2.54e-06	6.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KIT—sarcoma	2.46e-06	6.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—sarcoma	2.46e-06	6.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—sarcoma	2.39e-06	6.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CREB1—sarcoma	2.35e-06	6.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SRC—sarcoma	2.34e-06	6.32e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SRC—sarcoma	2.29e-06	6.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—sarcoma	2.25e-06	6.08e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—sarcoma	2.21e-06	5.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SRC—sarcoma	2.16e-06	5.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—sarcoma	2.12e-06	5.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—sarcoma	2.08e-06	5.61e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—sarcoma	2.05e-06	5.55e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—sarcoma	2.01e-06	5.43e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ENO2—sarcoma	2e-06	5.4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HBA1—sarcoma	1.99e-06	5.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MDM2—sarcoma	1.94e-06	5.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—sarcoma	1.94e-06	5.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—sarcoma	1.94e-06	5.23e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—sarcoma	1.9e-06	5.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—sarcoma	1.8e-06	4.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—sarcoma	1.79e-06	4.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—sarcoma	1.73e-06	4.68e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLCG1—sarcoma	1.7e-06	4.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—sarcoma	1.69e-06	4.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JUN—sarcoma	1.69e-06	4.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—sarcoma	1.67e-06	4.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—sarcoma	1.65e-06	4.45e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—sarcoma	1.61e-06	4.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—sarcoma	1.52e-06	4.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SRC—sarcoma	1.51e-06	4.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—sarcoma	1.47e-06	3.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—sarcoma	1.46e-06	3.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—sarcoma	1.36e-06	3.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—sarcoma	1.25e-06	3.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—sarcoma	1.11e-06	3.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—sarcoma	1.07e-06	2.88e-05	CbGpPWpGaD
